Candelaria Hernández M, López Karpovitch X, Javier Mijangos F, Montaño E, Lemus Carmona A, Guzmán Vázquez S, Soto Molina H. Cost-Effectiveness of Azacitidine Compared with Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS). Grhta [Internet]. 2017 May 31 [cited 2024 Nov. 22];4(1):114-21. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/385